Here we will look at a 147 mg/dL blood sugar level from a Glucose test result and tell you what it may mean. Is 147 mg/dL blood sugar good or bad? Note that blood sugar tests should be done multiple times and the 147 mg/dL blood sugar level should be an average of those numbers. According to the U.S. National Library of Medicine, there is a Fasting Glucose Test and a Random Glucose Test. Below you can see what different results may mean. Therefore, according to the chart above, if the 147 mg/dL blood sugar level was from a Fasting Glucose Test, then it may indicate diabetes. If the test result of a 147 mg/dL blood sugar level was from a Random Glucose Test, then the result would indicate it to be in the prediabetes range. Important: Our "Is 147 mg/dL Blood Sugar from a Glucose test normal?" page is for information only. Research Maniacs is not responsible for any errors or omissions. We strongly recommend that you see a doctor for all medical needs and that you ask your doctor to interpret any medical test results you receive. Go here to check if another blood sugar level is in the normal range. Is 148 mg/dL Blood Sugar from a Glucose test normal? Go here for the next blood sugar level on our list.
If you are evaluating what organic allulose is and how it works, the next question is inevitable: what does it actually do inside the body? Sweetness without consequence sounds appealing, but formulators, healthcare professionals, and informed consumers want evidence - not marketing language. This article walks through the current scientific understanding of allulose and its effects on blood sugar, insulin, calorie intake, kidney function, liver metabolism, gut tolerance, GlycoMode Wellness and long-term safety. Every claim here traces back to published research or regulatory determinations. Allulose has a glycemic index of approximately zero. It does not raise blood glucose and does not trigger a meaningful insulin response. This is not a marginal effect - it is a consistent finding across clinical trials. A double-blind crossover study published in the Journal of Nutritional Science and Vitaminology demonstrated that 5 g of allulose consumed with a meal significantly reduced postprandial blood glucose elevation compared to the same meal without allulose.
The mechanism appears to involve GLP-1 (glucagon-like peptide-1) stimulation: allulose encourages the release of this incretin hormone, which in turn slows gastric emptying and enhances insulin sensitivity. For food formulators, this means organic allulose sweetener can serve a functional role beyond sweetness - it actively helps blunt the glycemic impact of other carbohydrates in a formulation. For diabetic-friendly product claims, this is a meaningful differentiator. It is worth emphasizing that allulose does not lower blood sugar below normal levels. It moderates the spike. The effect is stabilizing, not hypoglycemic. Sugar delivers roughly 4 kcal per gram. Allulose delivers approximately 0.4 kcal per gram - about 90% fewer calories. The reason is straightforward: the human body largely cannot metabolize it. Unlike glucose, which is readily absorbed and oxidized for energy, allulose passes through metabolic pathways inefficiently. Most of what is absorbed is filtered by the kidneys and GlycoMode Wellness excreted in urine within 24 to 48 hours.
The small fraction that does undergo metabolism produces minimal caloric yield. This caloric profile has regulatory backing. The FDA permits allulose to be excluded from "Total Sugars" and "Added Sugars" declarations on Nutrition Facts labels (more on labeling nuances below). For product developers targeting calorie reduction without sacrificing mouthfeel or browning, this is one of the few options that works. A common concern - especially among consumers with kidney conditions - is whether a substance primarily excreted through urine places stress on renal function. Multiple toxicology studies, including a 90-day subchronic study and a two-year chronic toxicity study in rats, found no nephrotoxicity at doses far exceeding typical human consumption. Human clinical trials monitoring renal biomarkers (creatinine, BUN, eGFR) have similarly reported no adverse changes. The key distinction is between excretion through the kidneys and damage to the kidneys. Allulose is a small, water-soluble molecule that the kidneys filter efficiently - much like certain vitamins and electrolytes. Efficient filtration is not the same as toxic burden.
